Literature DB >> 11350093

The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction.

A Meirhaeghe1, C Bauters, N Helbecque, M Hamon, E McFadden, J M Lablanche, M Bertrand, P Amouyel.   

Abstract

AIMS: Abnormal coronary vasomotion plays a role in the clinical expression of coronary artery disease. We hypothesized that the functional C825T polymorphism located in the ubiquitous G-protein beta3 subunit, implicated in the cellular signal transduction of many receptors, could modify artery coronary vasomotion. We assessed the potential association of the pertussis toxin-sensitive G protein beta3 subunit (GNB3) gene C825T polymorphism on coronary vasomotion in humans. METHODS AND
RESULTS: We examined the response of angiographically normal human coronary arteries (n=131) after intravenous injection of methylergonovine maleate, a vasoconstrictor, followed by injection of isosorbide dinitrate, a vasodilator, according to GNB3 genotypes. Coronary vasomotion was assessed with quantitative coronary angiography. Subjects bearing at least one T allele had greater susceptibility to vasoconstriction in response to methylergonovine maleate than CC subjects, whereas vasodilation in response to isosorbide dinitrate did not differ among the different genotypes.
CONCLUSION: The C825T polymorphism of the G-protein beta3 subunit may be a genetic determinant of coronary artery vasomotion in humans. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350093     DOI: 10.1053/euhj.2000.2400

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study.

Authors:  Richard Sheppard; Eileen Hsich; Julie Damp; Uri Elkayam; Angela Kealey; Gautam Ramani; Mark Zucker; Jeffrey D Alexis; Benjamin D Horne; Karen Hanley-Yanez; Jessica Pisarcik; Indrani Halder; James D Fett; Dennis M McNamara
Journal:  Circ Heart Fail       Date:  2016-03       Impact factor: 8.790

2.  Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT.

Authors:  Amber E Johnson; Karen Hanley-Yanez; Clyde W Yancy; Anne L Taylor; Arthur M Feldman; Dennis M McNamara
Journal:  J Card Fail       Date:  2019-04-09       Impact factor: 5.712

Review 3.  Practical Pharmacogenomic Approaches to Heart Failure Therapeutics.

Authors:  Chayakrit Krittanawong; Amalia Namath; David E Lanfear; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-10

4.  β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Authors:  Marcus Dörr; Carsten O Schmidt; Thomas Spielhagen; Alexa Bornhorst; Katharina Hentschel; Christina Franz; Klaus Empen; Thomas Kocher; Scott R Diehl; Heyo K Kroemer; Henry Völzke; Ralf Ewert; Stephan B Felix; Dieter Rosskopf
Journal:  Pharmacogenomics       Date:  2010-09       Impact factor: 2.533

Review 5.  G-protein beta3 subunit 825T allele and hypertension.

Authors:  Winfried Siffert
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 6.  Vascular control in humans: focus on the coronary microcirculation.

Authors:  Yanping Liu; David D Gutterman
Journal:  Basic Res Cardiol       Date:  2009-02-03       Impact factor: 17.165

Review 7.  Evolution of blood pressure regulation in humans.

Authors:  J Hunter Young
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.